← Open Payments lookup

KERRY POWELL: Open Payments

NPI 1477092211 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$956 in 33 payments from 13 companies in 2025. Trend: 2023 $684 · 2024 $1,111 · 2025 $956

Food & beverage: $956
CompanyPaymentsAmount
ARGENX US, INC.5$242
Novartis Pharmaceuticals Corporation8$219
ABBVIE INC.7$154
Lundbeck LLC2$64
Janssen Biotech, Inc.2$55
Genentech USA, Inc.2$50
Neurocrine BioSciences, Inc.1$31
SK Life Science, Inc.1$31
Averitas Pharma Inc.1$24
Abbott Laboratories1$24

Products named: KESIMPTA, VYVGART, VYVGART HYTRULO, QULIPTA, VYEPTI, Ocrevus Zunovo, UBRELVY, INGREZZA.

Industry payments across FL — which companies pay providers there.